Page last updated: 2024-08-16

rivastigmine and 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol

rivastigmine has been researched along with 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fridkin, M; Youdim, MB; Zheng, H	1

Other Studies

1 other study(ies) available for rivastigmine and 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol

Article	Year
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy. Journal of medicinal chemistry, 2009, Jul-23, Volume: 52, Issue:14 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Brain; Cell Line, Tumor; Cell Survival; Chelating Agents; Cholinesterase Inhibitors; Drug Design; Humans; Hydroxyquinolines; Metals; Neuroprotective Agents; Piperazines; Prodrugs; Rats	2009

Article

Year

Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.

Journal of medicinal chemistry, 2009, Jul-23, Volume: 52, Issue:14

Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Brain; Cell Line, Tumor; Cell Survival; Chelating Agents; Cholinesterase Inhibitors; Drug Design; Humans; Hydroxyquinolines; Metals; Neuroprotective Agents; Piperazines; Prodrugs; Rats

2009